Research indicates that Intrinsa increases sexual drive in menopausal women

Intrinsa, a testosterone patch being developed by Procter & Gamble and Watson Pharma, increased the amount and quality of sex for menopausal women who tested it, according new research involving 549 women in the USA, Canada and Australia. The women using Intrinsa had sexual intercourse around four times more often than they usually did within two months, had better experiences and more positive self-images, while those using a placebo had only one additional session of sex, said Robin Kroll, a Seattle, USA-based gynecologist involved in the study. The Intrinsa group experienced a 48% increase in desire versus 20% in the placebo arm, as well as reporting a 52% decrease in distress, the researchers noted.